Shopping Cart
- Remove All
Your shopping cart is currently empty
Filanesib (ARRY-520) targets the kinesin spindle protein (KSP) with potential antineoplastic activity. ARRY-520 specifically inhibits KSP (kinesin-5 or Eg5), resulting in activation of the spindle assembly checkpoint, induction of cell cycle arrest during the mitotic phase, and consequently cell death in tumor cells that are actively dividing.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | $1,130 | 35 days |
| Description | Filanesib (ARRY-520) targets the kinesin spindle protein (KSP) with potential antineoplastic activity. ARRY-520 specifically inhibits KSP (kinesin-5 or Eg5), resulting in activation of the spindle assembly checkpoint, induction of cell cycle arrest during the mitotic phase, and consequently cell death in tumor cells that are actively dividing. |
| Targets&IC50 | KSP:6 nM (IC50) |
| Synonyms | Filanesib trifluoroacetic acid, ARRY-520 TFA, ARRY520 TFA, ARRY 520 TFA |
| Molecular Weight | 534.5 |
| Formula | C22H23F5N4O4S |
| Cas No. | 1781834-99-8 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.